You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 24, June 25, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Immunization
 •Adverse Effects
 •Alert me on articles by topic

Focal and Generalized Folliculitis Following Smallpox Vaccination Among Vaccinia-Naive Recipients

Thomas R. Talbot, MD, MPH; H. Keipp Bredenberg, MD; Michael Smith, MD; Bonnie J. LaFleur, PhD; Alan Boyd, MD; Kathryn M. Edwards, MD

JAMA. 2003;289:3290-3294.

Context  With the reintroduction of smallpox vaccination, detailed contemporary descriptions of adverse reactions to the vaccine are needed to adequately inform the public and clinicians. During a multicenter, randomized controlled trial investigating the efficacy of various dilutions of smallpox vaccine, we observed the appearance of a papulovesicular eruption (focal and generalized) in study volunteers.

Objective  To characterize the papulovesicular eruptions by clinical, virologic, and histopathological characteristics.

Design, Setting, and Participants  Prospective case series of papulovesicular eruptions following smallpox vaccination in healthy, vaccinia-naive adult participants compared with noncases conducted from October 2002 to March 2003. Variables potentially related to these eruptions were collected retrospectively through chart review. Eruptions were described based on viral culture, clinical examination, and histopathological evaluation (1 biopsy specimen from 1 case).

Main Outcome Measure  Cases of papulovesicular eruptions following vaccination.

Results  During the trial, of 148 volunteers (56% women; mean age 23.6 years), 4 participants (2.7%) developed generalized eruptions and 11 (7.4%) noted focal eruptions. Viral cultures of sample lesions were negative for vaccinia. The result of a skin biopsy sample from 1 case of generalized rash revealed suppurative folliculitis without evidence of viral infection. All lesions resolved without scarring. In the cohort, cases and noncases did not show significant differences in terms of sex, in the use of nonsteroidal anti-inflammatory drugs or oral or depo contraceptives, in medication allergies, in the incidence of fever or lymphadenopathy after vaccination, or in the dilution of vaccine received.

Conclusions  Folliculitis is a common and benign eruption observed in vaccinia-naive adult volunteers following smallpox vaccination. This eruption may be seen in volunteers receiving the vaccine in the newly instituted vaccination programs and may be met with heightened anxiety, potentially being confused with generalized vaccinia. This description of folliculitis using clinical, virologic, and histopathological findings should allay these concerns and provide additional insight into this eruption.


Author Affiliations: Departments of Medicine (Drs Talbot, Bredenberg, Smith, and Boyd), Pediatrics (Drs Smith and Edwards), Preventive Medicine (LaFleur), and Pathology (Dr Boyd), Vanderbilt University School of Medicine, Nashville, Tenn.


RELATED ARTICLES

US Military Smallpox Vaccination Program Experience
John D. Grabenstein and William Winkenwerder, Jr
JAMA. 2003;289(24):3278-3282.
ABSTRACT | FULL TEXT  

Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military Personnel
Jeffrey S. Halsell, James R. Riddle, J. Edwin Atwood, Pierce Gardner, Robert Shope, Gregory A. Poland, Gregory C. Gray, Stephen Ostroff, Robert E. Eckart, Duane R. Hospenthal, Roger L. Gibson, John D. Grabenstein, Mark K. Arness, and David N. Tornberg
JAMA. 2003;289(24):3283-3289.
ABSTRACT | FULL TEXT  

Response to Smallpox Vaccine in Persons Immunized in the Distant Past
Sharon E. Frey, Frances K. Newman, Lihan Yan, and Robert B. Belshe
JAMA. 2003;289(24):3295-3299.
ABSTRACT | FULL TEXT  

Smallpox Immunization in the 21st Century: The Old and the New
Mary E. Wright and Anthony S. Fauci
JAMA. 2003;289(24):3306-3308.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003
Casey et al.
JAMA 2005;294:2734-2743.
ABSTRACT | FULL TEXT  

Vaccination Success Rate and Reaction Profile With Diluted and Undiluted Smallpox Vaccine: A Randomized Controlled Trial
Talbot et al.
JAMA 2004;292:1205-1212.
ABSTRACT | FULL TEXT  

Risks of Smallpox Vaccination
Fulginiti
JAMA 2003;290:1452-1452.
FULL TEXT  

Smallpox Vaccine Safety
JWatch Infect. Diseases 2003;2003:1-1.
FULL TEXT  

Some Answers to Smallpox Vaccination Questions
JWatch General 2003;2003:1-1.
FULL TEXT  

Smallpox Immunization in the 21st Century: The Old and the New
Wright and Fauci
JAMA 2003;289:3306-3308.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.